Cor pulmonale: Difference between revisions

(Text replacement - "alpha" to "α")
No edit summary
Line 5: Line 5:
==Clinical Features==
==Clinical Features==
===Pathophysiology===
===Pathophysiology===
*Pulmonary vasoconstriction (hypoxia, acidemia)
*Pulmonary vasoconstriction ([[hypoxia]], [[acidosis|acidemia]])
*Destruction of pulmonary vasculature by emphysema, ILD
*Destruction of pulmonary vasculature by emphysema, [[interstitial lung disease]]
*Increased blood viscosity ([[sickle cell disease]], polycythemia)
*Increased blood viscosity ([[sickle cell disease]], [[polycythemia]])
===Chronic===
===Chronic===
*[[RVH]]
*[[RVH]]
Line 26: Line 26:
**[[Acute Valve Dysfunction]]
**[[Acute Valve Dysfunction]]
**[[Aortic Dissection]]
**[[Aortic Dissection]]
**[[Dysrhthymia]]
**[[Dysrhythmia]]
**[[Endocarditis]]
**[[Endocarditis]]
**[[Hypertensive Emergency]]
**[[Hypertensive Emergency]]
Line 43: Line 43:
===Blood tests===
===Blood tests===
*CBC (polycythemia)
*CBC (polycythemia)
*ABG (oxygenation, acid-base status)
*[[ABG]] (oxygenation, acid-base status)
*α-1-antitrypsin
*α-1-antitrypsin
*ANA
*ANA
*Coagulation studies (protein C/S, factor V Leiden etc)
*Coagulation studies (protein C/S, factor V Leiden etc)
===CXR===
===[[CXR]]===
*Enlarged pulmonary arteries
*Enlarged pulmonary arteries
*Cardiomegaly
*Cardiomegaly
*Decreased retrosternal air space
*Decreased retrosternal air space
===ECG===
===[[ECG]]===
*[[RVH]]
*[[RVH]]
*Right axis deviation
*Right axis deviation
Line 59: Line 59:
*S1 Q3 T3 in acute right heart strain
*S1 Q3 T3 in acute right heart strain
*Large P wave in II, III, aVF
*Large P wave in II, III, aVF
*Arrhythmia (PAC, SVT, MFAT, A-fib, A-flutter)
*[[Arrhythmia]] ([[PAC]], [[SVT]], MFAT, [[A-fib]], [[A-flutter]])


===Echo===
===[[Echocardiography]]===
*Increased RV thickness
*Increased RV thickness
*RV dilation
*RV dilation
Line 72: Line 72:
==Management==
==Management==
*Treat underlying disease
*Treat underlying disease
*Fluids, vasoconstrictors to support BP in acute setting
*Fluids, [[vasopressors|vasoconstrictors]] to support BP in acute setting
*Oxygen therapy: decreases pulmonary vasoconstriction
*[[Oxygen therapy]]: decreases pulmonary vasoconstriction
*Diuretics: decrease RV filling volume
*[[Diuretics]]: decrease RV filling volume
*[[Calcium channel blockers]]: vasodilate the pulmonary arteries
*[[Calcium channel blockers]]: vasodilate the pulmonary arteries
*Beta agonists (epoprostenol, iloprost): bronchodilate
*Beta agonists ([[epoprostenol]], iloprost): bronchodilate
*Phlebotomy for severe hypoxia leading to polycythemia
*Phlebotomy for severe hypoxia leading to polycythemia
*Lung transplant or heart-lung transplant as last resort
*Lung transplant or heart-lung transplant as last resort

Revision as of 18:36, 24 September 2019

Background

Clinical Features

Pathophysiology

Chronic

Acute

  • RV dilation

Signs and Symptoms

Differential Diagnosis

Evaluation

Blood tests

  • CBC (polycythemia)
  • ABG (oxygenation, acid-base status)
  • α-1-antitrypsin
  • ANA
  • Coagulation studies (protein C/S, factor V Leiden etc)

CXR

  • Enlarged pulmonary arteries
  • Cardiomegaly
  • Decreased retrosternal air space

ECG

Echocardiography

  • Increased RV thickness
  • RV dilation
  • Tricuspid insufficiency
  • High estimated PA pressures
  • Septal bowing into LV

CTPA for PE

V/Q scan for PE

Management

  • Treat underlying disease
  • Fluids, vasoconstrictors to support BP in acute setting
  • Oxygen therapy: decreases pulmonary vasoconstriction
  • Diuretics: decrease RV filling volume
  • Calcium channel blockers: vasodilate the pulmonary arteries
  • Beta agonists (epoprostenol, iloprost): bronchodilate
  • Phlebotomy for severe hypoxia leading to polycythemia
  • Lung transplant or heart-lung transplant as last resort

Disposition

See Also

External Links

References